REFERENCES
- Rossi Norrlund R, Holback D, Johansson L, Hietala S-0, Riklund Ählstrom K. Combinations of nonlabeled, 125I—la-beled, and anti—idiotypic, antiplacental alkaline phosphatase monoclonal antibodies at experimantal radioimmunotargeting. Acta Radiol 1997; 38: 1087–93.
- Rossi Norrlund R, Ullén A, Sandstrom P, et al. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies. Cancer 1997; 80: 2681–8.
- Ullén A, Sandstrom P, Rossi Norrlund R, et al. Dosimetry at fractionated administration of 125I-labeled antibody at experi-mental radioimmunotargeting. Cancer 1997; 80: 2510–8.
- Carlsson L, Sottrup-Jensen L, Stigbrand T. A two-site mono-clonal enzyme immunoassay for pregnancy-associated oc2-glyco-protein. J Immunol Methods 1987; 104: 73–9.
- Greenwood F, Hunter W, Glover J. The preparation of 131I-la-beled human growth hormone of high specific radioactivity. J Biochem 1963; 89: 114–23.
- Stabin M. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538–46.
- Charlton DE. The range of high LET effects from 1251 decays. Radiat Res 1986; 107: 163–71.